Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a global public health crisis. Liver injury has been reported during the COVID-19 disease progression.1 However, previous studies did not examine in detail the interaction of pre...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12266
- Acceso en línea:
- https://www.sciencedirect.com/science/article/pii/S0016508520305850
http://hdl.handle.net/20.500.12010/12266
https://doi.org/10.1053/j.gastro.2020.04.064
- Palabra clave:
- Coronavirus
Enfermedad cronica del higado
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Chronic Liver Disease
Cirrhosis
- Rights
- License
- Acceso restringido
| Summary: | Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a global public health crisis. Liver injury has been reported during the COVID-19 disease progression.1 However, previous studies did not examine in detail the interaction of preexisting liver disease and COVID-19.1 Therefore, we aimed to study the impact of preexisting liver disease on outcomes in a large cohort of patients with COVID-19 in the United States. |
|---|